Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Non Operating Income: 2013-2024

Historic Non Operating Income for Fortress Biotech (FBIO) over the last 12 years, with Dec 2024 value amounting to -$10.2 million.

  • Fortress Biotech's Non Operating Income rose 490.11% to $17.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.0 million, marking a year-over-year increase of 323.19%. This contributed to the annual value of -$10.2 million for FY2024, which is 9.98% up from last year.
  • Per Fortress Biotech's latest filing, its Non Operating Income stood at -$10.2 million for FY2024, which was up 9.98% from -$11.3 million recorded in FY2023.
  • Over the past 5 years, Fortress Biotech's Non Operating Income peaked at $24.2 million during FY2021, and registered a low of -$11.3 million during FY2023.
  • Over the past 3 years, Fortress Biotech's median Non Operating Income value was -$10.2 million (recorded in 2024), while the average stood at -$10.5 million.
  • Per our database at Business Quant, Fortress Biotech's Non Operating Income slumped by 193.67% in 2020 and then soared by 381.94% in 2021.
  • Fortress Biotech's Non Operating Income (Yearly) stood at -$8.6 million in 2020, then skyrocketed by 381.94% to $24.2 million in 2021, then tumbled by 140.93% to -$9.9 million in 2022, then dropped by 14.05% to -$11.3 million in 2023, then increased by 9.98% to -$10.2 million in 2024.